Peak Bio Inc (PKBO)

Currency in USD
0.023
0.000(0.00%)
Delayed Data·
Showing Peak Bio historical data. For real-time data please try another search
Day's Range
0.0230.024
52 wk Range
0.0220.024
Key Statistics
Prev. Close
0.023
Open
0.024
Day's Range
0.023-0.024
52 wk Range
0.022-0.024
Volume
-
Average Volume (3m)
16.67K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock

Peak Bio Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell

Peak Bio Inc Company Profile

Peak Bio, Inc. is engaged in the research and development of therapeutics, including small molecules and antibody-drug conjugates, for the treatment of cancer and rare diseases. The company develops small molecule inhibitors and antibody-drug conjugates for therapeutic use, with its lead product candidate, PHP-303, being an oral, once-daily small molecule inhibitor of neutrophil elastase for alpha-1 antitrypsin deficiency and COVID-19-related acute respiratory distress syndrome. It advances a proprietary toxin platform, including PH-1, a spliceosome modulator used to generate ADC product candidates targeting cancer, such as an ADC targeting the Trop2 antigen in solid tumors. The company conducts preclinical research activities and pharmacology studies, collaborating with contract research organizations and contract development and manufacturing organizations. It receives pre-clinical grants to support research and development efforts, with a pipeline focused on therapies for inflammatory, rare, and specialty diseases, as well as cancer. The company serves clients in the biotechnology, pharmaceutical, and medical device industries, organizations involved in oncology and rare disease research, research institutions, and government agencies. The company is based in Pleasanton, California.

Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
Nov 17, 2025
EPS / Forecast
0.21 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

PKBO Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.